30 Oct 2026

Italy’s draft 2027–2029 Budget Bill would establish a temporary route to medicines for serious and disabling conditions where no valid treatment alternative exists and treatment cannot be deferred. Article 72 reserves up to €70 million annually for the proposed route during 2027–2029.

The allocation would come from the existing Innovative Medicines Fund. Other designated uses of the fund would be reduced proportionately, so the proposal does not add €70 million to its total annual financing.

The new route would allow treatment before the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) has completed the ordinary public reimbursement decision. Early access would not predetermine the subsequent price, reimbursement class or assessment by AIFA’s Scientific and Economic Committee for Medicines.

A ministerial decree, proposed by AIFA and due by 28 February 2027 under the draft, would define application procedures, timing and eligibility. The bill also provides for withdrawal of early access in specified circumstances, including failure to submit a pricing and reimbursement dossier or failure to secure reimbursement within ten months of submission.

Where access is withdrawn for those reasons, manufacturers would be required to supply continued treatment without charge for qualifying existing patients for a limited period, generally up to 12 months.

The proposal would create a dedicated financing bridge between availability and ordinary reimbursement, separate from Italy’s existing managed access and innovation-fund arrangements. Its eventual operation depends on parliamentary approval and the implementing decree.

Source: President of the Italian Republic
Link: D.D.L. 30/10/2026 – Bilancio di previsione dello Stato per l’anno finanziario 2027 e bilancio pluriennale per il triennio 2027–2029 (Draft law of 30 October 2026 – State Budget for 2027 and multiannual Budget 2027–2029)
Date: 30 October 2026

Source: Il Farmacista Online
Link: Manovra. Ecco il testo con tutte le misure per la sanità e la farmaceutica (Budget: full text and measures for healthcare and pharmaceuticals)
Date: 30 October 2026